|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||1.7000 - 1.7000|
|52 Week Range||1.5800 - 3.5100|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||10.63|
|Forward Dividend & Yield||0.07 (4.25%)|
|Ex-Dividend Date||Jun 08, 2023|
|1y Target Est||N/A|
The board of Dr. Martens plc ( LON:DOCS ) has announced that it will pay a dividend on the 18th of July, with investors...
It looks like Dr. Martens plc ( LON:DOCS ) is about to go ex-dividend in the next 2 days. The ex-dividend date is one...
Dr. Martens ( LON:DOCS ) Full Year 2023 Results Key Financial Results Revenue: UK£1.00b (up 10% from FY 2022). Net...
British brand’s profits tumble after string of errors in US operation hits sales
British equities gained in a broader market rally on Thursday with higher metal prices supporting miners, while progress on the bill to lift the U.S. debt ceiling further spurred risk appetite. The internationally-focused FTSE 100 gained 0.6% as the U.S. debt ceiling bill successfully passed through the House of Representatives and was headed for a vote in the Senate. "The fact that it looks like the world can put the U.S. debt ceiling silliness behind is certainly a modest positive," said Steve Sosnick, chief strategist at Interactive Brokers.
Dr Martens flagged lower profit margins for 2024 fiscal year after the British bootmaker posted a slump in its annual profit on Thursday, citing higher investments to tackle supply chain and operational snags. Dr Martens has also seen its costs mount due to problems at its Los Angeles distribution centre, which opened last year. "The operational issues experienced during FY23 have demonstrated that continuing to invest in our infrastructure and capabilities to support our increasing scale and underpin our long-term growth is the right thing to do," the company said in a statement, adding that it still expects price increases to cover supply chain cost inflation.
(Reuters) -Dr Martens shares dropped more than 10% on Thursday after the British bootmaker warned investments would hit profit margins this financial year and the consumer backdrop in the United States "was the toughest in the world at the moment". The U.S. is the company's second-largest market and weakness there contributed to a drop in core earnings of more than a quarter in the year ended March 31. Dr Martens, whose pricey work boots have been fashionable since the 1960s, has been struggling with waning demand in the U.S. as consumers cut back on discretionary spending amid high inflation.
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
(Reuters) -Dr Martens issued its third profit warning in five months on Friday, as it struggled with higher-than-expected costs at a new Los Angeles (LA) distribution centre. The British company, whose pricey work boots have been fashionable since the 1960s, also said its Chief Financial Officer Jon Mortimore would leave once it finds a replacement. Mortimore's resignation comes as Dr Martens issued its third profit warning since November, when it flagged a sharp hit to profit margins on weaker-than-expected demand before Christmas.
Key Insights Dr. Martens' estimated fair value is UK£1.94 based on 2 Stage Free Cash Flow to Equity Dr. Martens is...
Dr. Martens (LON:DOCS) has had a rough three months with its share price down 42%. However, a closer look at its sound...
What's more goth than blaming your woes on the sunshine? Dr. Martens, the maker of the steel-toed boots favored by punks, goths, and...
Bootmaker’s reversal of its growth promises has damaged the reputation of the UK IPO market
Dr Martens lost a quarter of its value after it warned on profits as chaos at a new warehouse led to boots piling up.
The company has downgraded its outlook for the financial year.
Bootmaker’s shares fall as US warehouse problems, along with strikes and staff shortages in Europe, dent profits
The UK blue chip index finished lower on revived concerns about recession and rate rises.
Dr. Martens plc ( LON:DOCS ) shareholders should be happy to see the share price up 11% in the last month. But that is...
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Dr. Martens plc ( LON:DOCS ) will increase its dividend on the 3rd of February to £0.0156, which is 28% higher than...
Share plunge may look like an overreaction but profits are forecast to fall and the boot maker was clearly overpriced at IPO
Northamptonshire-based footwear group’s half-year results show 5% fall in profits despite 13% rise in sales
The bootmaker said that its annual core profit margin would be lower than last year as it battles economic headwinds plaguing the retail sector, such as rising inflation and the cost of living crisis.
The UK bootmaker said direct-to-consumer sales – those from its own stores and websites – were ‘slower than anticipated’.